Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Catherine Brennan is active.

Publication


Featured researches published by Catherine Brennan.


Bioorganic & Medicinal Chemistry Letters | 2000

1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors

Jacques Dumas; Holia Hatoum-Mokdad; Robert Sibley; Bernd Riedl; William J. Scott; Mary Katherine Monahan; Timothy B. Lowinger; Catherine Brennan; Reina Natero; Tiffany Turner; Jeffrey S Johnson; Robert W. Schoenleber; Ajay Bhargava; Scott Wilhelm; Timothy J Housley; Gerald Ranges; Alka Shrikhande

Inhibitors of the MAP kinase p38 are potentially useful for the treatment of arthritis and osteoporosis. Several 2,3-dichlorophenyl ureas were identified as small-molecule inhibitors of p38 by a combinatorial chemistry effort. Optimization for cellular potency led to the discovery of a new class of potent and selective p38 kinase inhibitors, exemplified by the 1-phenyl-5-pyrazolyl urea 7 (IC50 = 13 nM).


Archive | 1998

INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS

Scott Miller; Martin Osterhout; Jacques Dumas; Uday Khire; Timothy B. Lowinger; William J. Scott; Roger A. Smith; Jill E. Wood; David E. Gunn; Holia Hatoum-Mokdad; Marell Rodriguez; Robert Sibley; Ming Wang; Tiffany Turner; Catherine Brennan


Archive | 1998

Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas

Scott Miller; Martin Osterhout; Jacques Dumas; Uday Khire; Timothy B. Lowinger; Bernd Riedl; William J. Scott; Roger A. Smith; Jill E. Wood; David E. Gunn; Ming Wang; Tiffany Turner; Catherine Brennan


Archive | 2002

2-phenylamino-4-(5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, src kinase inhibitors

Julie Dixon; William J. Scott; Jacques Dumas; Catherine Brennan; Holia Hatoum-Mokdad


Archive | 2003

2-4-(di-phenyl-amino)-pyrimidine derivatives useful for treating hyper-proliferative disorders

Jill E. Wood; Donald Bierer; Brian Bear; Catherine Brennan; Brent Chandler; Gang Chen; Yuanwei Chen; Julie Dixon; Wenlang Fu; Leatte Guernon; Donglei Liu; Andrea Mcclure; Karl Miranda; Dhanapalan Nagarathnam; Robert Sibley; Michael Robert Turner; Sharad Verma; Chunguang Wang; Lin Yi; Jin Zhao; Qingming Zhu


Archive | 2001

17-Beta-hydroxysteroid dehydrogenase-II inhibitors

Jill E. Wood; Jeremy L. Baryza; Catherine Brennan; Soongyu Choi; James H. Cook; Brian R. Dixon; Paul Ehrlich; David Gunn; Ian McAlexander; Derek Lowe; Aniko Redman; William J. Scott; Yamin Wang


Archive | 2002

Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents

Jacques Dumas; Robert Sibley; Roger A. Smith; Ning Su; Yuanwei Chen; Jill E. Wood; Leatte Guernon; Julie Dixon; Catherine Brennan; Stephen Boyer


Archive | 1999

SUBSTITUTED 2-ARYLIMINO HETEROCYCLES AND COMPOSITIONS CONTAINING THEM, FOR USE AS PROGESTERONE RECEPTOR BINDING AGENTS

Brian R. Dixon; Cedo M. Bagi; Catherine Brennan; David R. Brittelli; William H. Bullock; Jinshan Chen; William L. Collibee; Robert Dally; Jeffrey Johnson; Harold C. E. Kluender; William F. Lathrop; Carol Ann Mase; Aniko Redman; William J. Scott; Klaus Urbahns; Donald John Wolanin


Archive | 2005

Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis

Julie A. Dixon; Catherine Brennan; Karl Miranda; Brent Chandler; Barton Phillips; Jianmei Fan; Michael Brands; Andrea Mcclure; Benjamin Jones; Wenlang Fu; Donald Bierer; Steven Magnuson; Harold C. E. Kluender


Tetrahedron Letters | 2005

4,5-disubstituted cis-pyrrolidinones as inhibitors of 17β-hydroxysteroid dehydrogenase II. Part 1: Synthetic approach

James H. Cook; Jeremy Barzya; Catherine Brennan; Derek Lowe; Yamin Wang; Aniko Redman; William J. Scott; Jill E. Wood

Collaboration


Dive into the Catherine Brennan's collaboration.

Top Co-Authors

Avatar

Julie Dixon

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge